Myriad Genetics reported $106M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agilent A:US USD 1.01B 73M
Becton, Dickinson and BDX:US USD 2.08B 9M
Bio Rad Laboratories BIO:US USD 375.09M 20.89M
Bruker BRKR:US USD 335.1M 35.6M
Danaher DHR:US USD 4.58B 137M
Exact Sciences EXAS:US USD 375.14M 1.9M
Fluidigm FLDM:US USD 9.22M 4.79M
Hologic HOLX:US USD 522.9M 36.1M
Illumina ILMN:US USD 717M 50M
Johnson & Johnson JNJ:US USD 15.98B 134M
Mettler Toledo International MTD:US USD 584.66M 13M
Myriad Genetics MYGN:US USD 106M 23.6M
Orasure Technologies OSUR:US USD 46.19M 18.61M
Quest Diagnostics DGX:US USD 874M 28M
Repligen RGEN:US USD 114.23M 7.15M
Thermo Fisher Scientific TMO:US USD 4.43B 168M
Veracyte VCYT:US USD 49.58M 1.75M
Waters WAT:US USD 401.45M 5.66M